Cargando…
AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes
BACKGROUND: The AZTEC trial is a multi-centre, randomised, placebo-controlled trial of azithromycin to improve survival without development of chronic lung disease of prematurity (CLD) in preterm infants. The statistical analysis plan for the clinical outcomes of the AZTEC trial is described. METHOD...
Autores principales: | Lau, Tin Man Mandy, Lowe, John, Pickles, Timothy, Hood, Kerenza, Kotecha, Sailesh, Gillespie, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396905/ https://www.ncbi.nlm.nih.gov/pubmed/35999617 http://dx.doi.org/10.1186/s13063-022-06604-2 |
Ejemplares similares
-
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants
por: Lowe, John, et al.
Publicado: (2020) -
Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants—study protocol for the AZTEC-FU study
por: Kotecha, Sarah J., et al.
Publicado: (2022) -
Biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: statistical analysis plan for the BATCH trial and PRECISE sub-study
por: Schoenbuchner, Simon M., et al.
Publicado: (2023) -
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
por: Sivapalan, Pradeesh, et al.
Publicado: (2020) -
Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan
por: Westendorp, Willeke F, et al.
Publicado: (2014)